A globally unique 19F, 13C, 15N NMR system to enable frontier bioscience
A globally unique 19F, 13C, 15N NMR system to enable frontier bioscience
批准号:
BB/V019163/1
负责人:
Matthew Crump
金额:
$87.9万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --
中文摘要
我们使用一种称为核磁共振波谱(NMR)的技术来研究形成细胞和生物体复杂机制的生物分子的结构。它们的结构决定了它们如何工作和相互作用,并形成了理解前沿生物科学的相当大的人类努力的基础。我们提议购买世界上第一个TXO-HF NMR低温探针技术,并将其用于帕金森氏病等神经退行性疾病领域的突破性发现,设计新的生物分子结构,或生产抗病毒,抗生素和抗真菌化合物。我们还可以利用这些新的核磁共振数据来设计或重新设计药物,使它们更有效,甚至看看当你的身体试图代谢它们时,下一代药物会发生什么。我们已经确定了这台仪器将从第一天起支持的3000万英镑资助的研究项目、国家合作和博士培训项目,我们正在与一系列国家网络合作,他们将允许我们在核磁共振仪器的使用寿命内大幅增加这一数字。新的探针将使这项研究成为可能,因为核磁共振与医院里发现的全身核磁共振扫描仪有着相同的基本原理。然而,当研究生物科学中的分子时,很难用我们的核磁共振光谱仪获得足够的样本来检测,而核磁共振研究的“标准”原子核(质子)往往是如此丰富,以至于它给出了非常“嘈杂”的光谱,其中有太多的信号,我们无法解释。解决这些问题的方法是使用一种核磁共振“冷冻探针”,它具有非常灵敏的探测能力,并且经过优化,可以观察其他类型的原子核,这些原子核往往会发出更多的扩散信号。一些核磁共振系统已经开始使用碳核和氮核,但我们要安装的这个TXO-HF系统之所以特别强大,是因为它还可以使用另一种核,氟,它作为探针的功能非常强大,因为它在大多数自然系统中都很少见。这意味着我们可以使用尖端的生物合成技术将氟引入我们研究的分子中,然后在没有质子核磁共振发现的所有背景噪音的情况下跟踪它的行为,从而研究生物学中一些非常困难的问题。有许多更重要和复杂的科学问题需要用这种新设备来回答,为了做到这一点,我们与许多合作伙伴大学、国家核磁共振网络项目和生物制药公司合作。通过将所有这些不同的团体聚集在一起,我们确保我们最大限度地增加人员数量,并拥有广泛的专业知识,可以应用于我们面临的科学挑战。随着全国大学合作的发展,像这样共享(昂贵的!)独特而复杂的设备变得越来越重要。因此,我们对这台设备的部分目的是用它作为一个范例,鼓励我们熟练的研究技术专业人员进行合作和培训,他们操作这些仪器,同时也激励那些自己将继续成为未来生物科学研究人员和核磁共振波谱学家的学生。为了做到这一点,我们与一个专门的团队合作,他们支持这个想法,我们希望通过这个团队使设备更具影响力和可持续性。
英文摘要
We use a technique called Nuclear Magnetic Resonance spectroscopy (NMR) to study the structure of biomolecules that form the intricate machinery of cells and organisms. Their structure determines how they work and interact with each other and forms the basis of considerable human effort in understanding cutting edge bioscience. We are proposing to purchase the world's first TXO-HF NMR cryogenic probe technology and use it to make ground-breaking discoveries in areas such as neurodegenerative conditions like Parkinson's disease, design the structure of new biomolecules, or the production of antiviral, antibiotic and antifungal compounds. We can also use this new NMR data to design or repurpose drugs to make them more potent and even look at what happens to next generation drugs when your body tries to metabolise them. We have already identified >£30m of funded research programs, national collaborations and doctoral training programs that this instrument will underpin from day one, and we are working with a range of national networks who will allow us to increase this substantially over the lifetime of the NMR instrument. The new probe will enable this research because NMR shares the same basic ideas as the whole-body MRI scanners that are found in hospitals. However when studying molecules in bioscience, it is difficult to get enough sample to detect with our NMR spectrometer and the 'standard' atomic nucleus that MRI studies (the proton), tends to be so abundant that it gives very 'noisy' spectra with too many signals for us to be able to interpret. The solution to these problems is to use an NMR 'cryoprobe' that has very sensitive detection and is optimised to look at other types of atomic nuclei that tend to give more spread-out signals. Some NMR systems have started to use carbon and nitrogen nuclei, but what makes this TXO-HF system we are going to install especially powerful is that it can also use a further nucleus, fluorine, that is uniquely powerful as a probe because it is rare in most natural systems. This means we can use cutting-edge biosynthetic techniques to introduce fluorine into the molecules we study and then follow it's behaviour without all of the background noise that is found with proton-based NMR and thus study some very difficult problems in biology. There are many more important and complex scientific questions to answer with this new equipment and to do this we have teamed up with many partner universities, national NMR network programs and biopharmaceutical companies. By bringing all of these different groups together we are ensuring we maximise the number of people and have a broad expertise that can be applied to the scientific challenges we face. As the national picture of how universities work together evolves, sharing (expensive!) unique and sophisticated equipment like this becomes ever more important. Therefore part of what we are seeking to do with this equipment is use it as an exemplar to encourage collaboration and training for our skilled research technical professionals who run these instruments, as well as to inspire the students who themselves will go on to be the bioscience researchers and NMR spectroscopists of the future. To do this we have engaged with a dedicated team who champion this idea and through which we hope to make the equipment even more impactful and sustainable.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/anie.202212393
发表时间:
2022-12-12
期刊:
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子:
16.6
作者:
[Winter, Ashley J., Rowe, Matthew T., Weir, Angus N. M., Akter, Nahida, Mbatha, Sbusisiwe Z., Walker, Paul D., Williams, Christopher, Song, Zhongshu, Race, Paul R., Willis, Christine L., Crump, Matthew P.]
通讯作者:
Crump, Matthew P.
DOI:
10.1107/s2059798323006514
发表时间:
2023-10-01
期刊:
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
影响因子:
2.2
作者:
[Cavini,Italo A., Winter,Ashley J., Garratt,Richard C.]
通讯作者:
Garratt,Richard C.
Tricyclic octaurea "Temples" for the recognition of polar molecules in water.
三环八脲“寺庙”用于识别水中的极性分子。
DOI:
10.1039/d2ob02061k
发表时间:
2023
期刊:
Organic & biomolecular chemistry
影响因子:
3.2
作者:
[Webster CS]
通讯作者:
Webster CS
Redox-powered autonomous unidirectional rotation about a C-C bond under enzymatic control
在酶控制下,氧化还原驱动的围绕 C-C 键的自主单向旋转
DOI:
10.26434/chemrxiv-2024-tz8vc
发表时间:
2024
期刊:
影响因子:
--
作者:
[Collins B]
通讯作者:
Collins B
Programmed Iteration Controls the Assembly of the Nonanoic Acid Side Chain of the Antibiotic Mupirocin
程序化迭代控制抗生素莫匹罗星壬酸侧链的组装
DOI:
10.1002/ange.202212393
发表时间:
2022
期刊:
Angewandte Chemie
影响因子:
--
作者:
[Winter A]
通讯作者:
Winter A
共 6 条
New tools for elucidating natural product biosynthesis in-situ at atomic resolution
-
批准号:BB/W008823/1
-
项目类别:Research Grant
-
资助金额:$99.73万
-
财政年份:2022
-
负责人:Matthew Crump
-
依托单位:
Acquisition of hierarchical control in skilled action sequencing
-
批准号:1353360
-
项目类别:Continuing Grant
-
资助金额:$35.61万
-
财政年份:2014
-
负责人:Matthew Crump
-
依托单位:
Protein-ligand coupled motions in DHFR catalysis
-
批准号:BB/J005398/1
-
项目类别:Research Grant
-
资助金额:$14.5万
-
财政年份:2012
-
负责人:Matthew Crump
-
依托单位:
The role of intermediate binding in Type I and Type II acyl carrier proteins
-
批准号:BB/F014570/1
-
项目类别:Research Grant
-
资助金额:$43.56万
-
财政年份:2008
-
负责人:Matthew Crump
-
依托单位:
国内基金
海外基金
微分动力系统的测度和熵
-
批准号:11101447
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:孙鹏
-
依托单位: